Clayface Loses 532 Theaters in Week Three But Crosses $92 Million Worldwide

DC Studios’ Clayface lost 532 North American theaters in its third week of release, a standard exhibition contraction that leaves the Warner Bros. thriller playing in 3,946 locations.

The James Watkins-directed film has already cleared more than $92 million worldwide after two weeks against a reported $44 million budget, keeping the body-horror gamble comfortably in the black.

Why a Theater Drop Is Not a Collapse for a Lean DC Bet

Opening in 3,478 theaters on October 23, the film’s third-frame footprint of 3,946 locations actually represents a net expansion across the wider marketplace. The 532-theater reduction reflects screens being reclaimed by incoming wide releases rather than any studio retreat.

Watkins, working from a Mike Flanagan screenplay, built the film around Matt Hagen’s disfigurement and an experimental medical procedure that turns an aspiring Hollywood actor into a Gotham grotesque. That premise demands practical prosthetic work and claustrophobic set craft over green-screen spectacle.

The result sits closer to a contained psychological horror piece than a superhero tentpole, a distinction that keeps its negative cost lean and its break-even point low. It also separates the film from the broader action-franchise churn tracked across our industry release desk.

Tom Rhys Harries Anchors a Cast Built for Texture

Tom Rhys Harries carries the title role, with Naomi Ackie as scientist Caitlyn Corr providing the film’s grounded counterweight. David Dencik, Max Minghella, Eddie Marsan, Nancy Carroll, and Joshua James round out an ensemble weighted toward character actors rather than marquee names.

That casting choice keeps the budget disciplined and the performances sharp, trading star wattage for the kind of ensemble density that plays well with adult audiences. It also mirrors the mid-budget genre swing seen in comparable action releases courting the same post-opening crowds.

A Halloween Corridor, a 94% Audience Score, and the Real Margin

The October 23 domestic launch planted the film directly in the pre-Halloween window, a corridor that rewards horror-adjacent material with elevated weekday turnout. A 78% critics’ score alongside a 94% audience score signals a crowd-pleaser that critics respect without championing.

That gap between professional and audience response is the film’s commercial engine. Word-of-mouth on a $44 million production does not need to be universal, it needs to be loud enough to hold screens through the holiday frame.

With worldwide gross already past twice the reported budget before marketing and distribution costs, the theatrical run has effectively secured its position. The coming weeks will determine whether the audience score converts into a longer tail or a swift handoff to home entertainment.